Oruka Therapeutics, Inc.
Develops novel biologics for chronic skin diseases and inflammatory conditions.
ORKA | US
Overview
Corporate Details
- ISIN(s):
- US6876041087 (+1 more)
- LEI:
- Country:
- United States of America
- Address:
- 855 OAK GROVE AVE., 94025 MENLO PARK
- Website:
- https://orukatx.com/
- Sector:
- Manufacturing
Description
Oruka Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops novel biologics for chronic skin diseases and other inflammatory conditions. The company applies advanced antibody engineering to validated modes of action to create potentially best-in-class monoclonal antibodies. Its lead program, ORKA-001, targets the IL-23 cytokine for the treatment of moderate-to-severe plaque psoriasis. Oruka's mission is to redefine the standard of care by developing treatments that achieve high rates of complete disease clearance with a significantly reduced dosing frequency, potentially requiring only one or two doses per year.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-12-11 22:41 |
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
English | 7.2 KB | ||
| 2025-12-11 22:32 |
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
|
English | 10.8 KB | ||
| 2025-12-11 22:10 |
CURRENT REPORT
|
English | 97.5 KB | ||
| 2025-11-14 23:35 | English | 11.1 KB | |||
| 2025-11-12 22:02 |
QUARTERLY REPORT
|
English | 1.5 MB | ||
| 2025-11-05 22:24 |
PROSPECTUS
|
English | 96.0 KB | ||
| 2025-11-05 22:23 |
PROSPECTUS
|
English | 70.2 KB | ||
| 2025-10-18 00:41 | English | 12.6 KB | |||
| 2025-10-14 22:44 |
AMENDMENT NO. 1 TO FORM S-3
|
English | 114.0 KB | ||
| 2025-10-14 22:43 |
AMENDMENT NO. 1 TO FORM S-3
|
English | 124.0 KB | ||
| 2025-10-03 23:28 |
REGISTRATION STATEMENT
|
English | 240.6 KB | ||
| 2025-10-03 23:19 |
REGISTRATION STATEMENT
|
English | 154.3 KB | ||
| 2025-09-24 23:11 | English | 15.3 KB | |||
| 2025-09-22 22:26 |
PROSPECTUS SUPPLEMENT
|
English | 227.0 KB | ||
| 2025-09-22 22:26 |
CURRENT REPORT
|
English | 438.2 KB |
Automate Your Workflow. Get a real-time feed of all Oruka Therapeutics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Oruka Therapeutics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Oruka Therapeutics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
